Analysis of RedHill Biopharma manpower and management performance can provide insight into RedHill Biopharma stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with RedHill Biopharma future performance. Additionally take a look at Your Equity Center.
RedHill Biopharma Management Effectiveness
The company has return on total asset (ROA) of (54.98) % which means that it has lost $54.98 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (98.45) % meaning that it generated substantial loss on money invested by shareholders.
The output start index for this execution was zero with a total number of output elements of seventeen. RedHill Biopharma Price Series Summation is a cross summation of RedHill Biopharma price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.
RedHill Biopharma Stakeholders
Ori Shilo Co-Founder and Deputy CEO of Fin. and Operations
RedHill Biopharma employes about 74 people. The company is managed by 27 executives with total tenure of roughly 113 years, averanging almost 4.0 years of service per executive having 2.0 employee per reported executive.
RedHill BiopharmaManpower Efficiency
Return on RedHill Biopharma Manpower
Revenue Per Employee
Revenue Per Executive
Net Loss Per Employee
Net Loss Per Executive
Working Capital Per Employee
Working Capital Per Executive
Additionally take a look at Your Equity Center. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..